Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

COVID-19: FDA Committee Recommends Updated Vaccine

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) on June 15 advised COVID-19 vaccine manufacturers to develop vaccines with a monovalent XBB 1.5 composition in time for the fall.

XBB is a subvariant of SARS-CoV-2, the virus that causes COVID-19.

The VRBPAC suggested manufacturers no longer factor in the original strain of the virus into the development of vaccines, citing the global dominance of the XBB descendent lineages and the high level of baseline immunity to the ancestral virus strain.

Visit the America’s Essential Hospitals coronavirus resource page for more information about the pandemic.

Contact Senior Director of Policy Erin O’Malley at or 202.585.0127 with questions.


About the Author

Andrea Lugo is a communications associate at America's Essential Hospitals.

where to buy viagra
buy lasix
buy doxycycline
buy trazodone
buy famvir
buy metoprolol
where to buy methylprednisolone
where to buy disulfiram
canadian pharmacy
buy albuterol inhaler
buy cialis online
prednisone otc
where to buy accutane
buy abilify
buy domperidone
buy neurontin
where to buy zithromax online
buy synthroid
ivermectin otc
buy strattera online
metformin otc
clomid online
nitrofurantoin otc
online drugstore
where to buy flagyl
where to buy diflucan
mexican pharmacy
misoprostol online
discount pharmacy
buy zoloft online
citalopram online
hydroxyzine online
kaletra online
Previous Next
Test Caption
Test Description goes like this